Suven announces merger of Cohance Lifesciences
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
The board gave in-principle approval for expansion of company's footprint in Lucknow
We are achieving the target of developed India by making our young children healthy today
The agreement sets terms under which POC will manufacture the product or receive royalties
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
Subscribe To Our Newsletter & Stay Updated